$RKLB

Rocket Lab revenue hits a record US$234 million while the losses keep coming

Rocket Lab reported record Q2 revenue of US$234.1 million, up 62% year over year, with gross profit rising to US$84.6 million and gross margin to 36.1%. It posted a net loss of US$49.3 million. Backlog rose to US$2.36 billion. Guidance for Sept quarter: revenue US$250-265 million; adjusted loss US$17-23 million; gross margin 29-31%. Shares fell after results.

Original reporting
Published Aug 11, 2026, 5:30 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 11, 2026, 5:42 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Rocket Lab revenue hits a record US$234 million while the losses keep coming — source image
Decision brief

The 30-second read

$RKLBNeutralMed
01

Why it matters

Traders will likely reprice the balance between demand visibility (order book) and near-term profitability (gross margin and adjusted loss guidance), while also monitoring the Iridium deal’s approval path and Neutron production milestones.

02

Market read

Record revenue and backlog growth were not enough to offset guidance for lower gross margin and a wider adjusted loss, contributing to after-hours weakness.

03

What to watch

Execution risk on Neutron timing and Iridium regulatory/approval hurdles may dominate near-term valuation more than the headline revenue growth.

Relevance 8/10Novelty 7/10Timing: post-market Q2 results and same-day after-hours selloff; September-quarter guidance in focus

Background

Rocket Lab posted its biggest quarter in history, but remains unprofitable and is scaling Neutron while pursuing vertical integration via acquisitions.

Company-level read

Ticker impact

$RKLBNeutralMedium confidence
Context

Rocket Lab reported Q2 revenue of $234.1M, guided Q3 revenue to $250M-$265M, and forecast adjusted loss widening to $17M-$23M.

Expected impact

Likely choppy trading with downside bias until Neutron milestones and backlog-to-revenue conversion become clearer.

Evidence & confidence

The article contains fresh, decision-relevant guidance (revenue, adjusted loss, gross margin) plus a large pending acquisition (Iridium) that can add execution and financing risk.

Market effects

Reinforces the space-launch model tradeoff: strong order momentum but continued losses and margin pressure during scaling and rocket development.

Limited direct NZ market impact, but highlights Rocket Lab’s ongoing Auckland manufacturing and launch cadence.

Iridium acquisition and Neutron development are relevant to broader LEO communications and medium-lift launch capacity narratives.

Counterpoint

The backlog jump and new contract intake could translate into faster revenue conversion than the market expects, making the loss widening a temporary scaling artifact.

Key entities

  • Rocket Lab

    Nasdaq-listed launch and space systems company reporting Q2 results, backlog growth, and September-quarter guidance.

  • Iridium Communications

    Satellite communications operator Rocket Lab agreed to acquire for about $8B enterprise value, pending approvals.

  • Neutron

    Rocket Lab’s medium-lift rocket program, with first-stage tank delivery tracking to the final quarter of this year.

Related articles

$RKLBMed

Rocket Lab USA, Hims & Hers, AST SpaceMobile, Archer Aviation and Plug Power: Why These 5 Stocks Are on I

U.S. indices fell Monday. The article highlights five stocks: Rocket Lab (down 3.37% to $80.04) ahead of Q2 results; analysts expect an 8-cent loss on $231.1M revenue, with a $397M Space Force contract. Hims & Hers (up 0.57% to $31.77) raised 2026 revenue guidance to $3.1B-$3.3B. AST SpaceMobile (down 4.42% to $68.76) missed Q2 revenue and reaffirmed 2026 outlook. Archer Aviation (up 11.99% to $6.26) reported Q2 revenue $5M and $1.56B cash. Plug Power (down 3.21% to $2.11) beat Q2 estimates and

$RKLBHighAI 9/10

Rocket Lab revenue climbs 62% as backlog reaches record $2.36 billion

Rocket Lab reported Q2 revenue of $234.1 million, up 62% year over year, driven by product sales rising to $181.3 million. Gross profit increased to $84.6 million and gross margin to about 36%. Backlog hit a record $2.36 billion. The company forecast Q3 revenue of $250 million to $265 million and expects an adjusted EBITDA loss of $17 million to $23 million.

$RKLBMedAI 8/10

Rocket Lab (RKLB) Q2 2026: Record Revenue, Acquisitions Dent EPS

Rocket Lab reported Q2 2026 revenue of $234.07M, above the $230.94M consensus, up 62% year over year. Product revenue rose to $181.35M. GAAP EPS was -$0.08 versus -$0.0767, with the miss linked to $8.6M acquisition-related transaction costs. Backlog grew to $2.36B and Q3 revenue guidance was $250M-$265M.

$RKLBMedAI 8/10

Rocket Lab Just Delivered Record Results. So Why Is the Stock Sinking?

Rocket Lab (RKLB) reported Q2 record revenue of $234 million, up 62% year over year, and a net loss of $49 million, or $0.08 per share. Revenue beat consensus ($231.6 million) but loss was wider than expected ($0.03). Backlog rose 137% to $2.36 billion, with $1B+ new contracts and $397 million U.S. Space Force Flatellites deal. Q3 revenue guidance is $250-$265 million.

$RKLBHighAI 8/10

Live: Will Rocket Lab Soar Back to All-Time Highs After Q2 Earnings Tonight?

Rocket Lab (NASDAQ:RKLB) is set to report Q2 FY2026 earnings on Aug. 10. Management guided Q2 revenue to $225M-$240M, about 60% YoY growth, supported by a $2.2B backlog and recent defense contract wins including a $266M Space Force suborbital contract and $397M Flatellites award. The article highlights Neutron timing and margin deceleration as key investor focus.